The aim of this study was to identify patients with abnormal levels of alpha-galactosidase A, lyso-Gb3 and genetic variants associated with Fabry disease among 829 kidney transplant recipients (KTRs) as well as to explore potential risk factors associated with abnormal alpha-galactosidase A and lyso Gb3 levels. Here, GLA is linked to Fabry disease.